Marta Dueñas Porto The Liquid Biopsy and Biomarker Working Module the Biomedical Research Network in Cancer (CIBERONC) Biography Publications Institution JoVE Articles Marta Dueñas Porto has not added a biography. If you are Marta Dueñas Porto and would like to personalize this page please email our Author Liaison for assistance. Publications BlaDimiR: A Urine-based MiRNA Score for Accurate Bladder Cancer Diagnosis and Follow-up European Urology. Sep, 2022 | Pubmed ID: 36085102 Macrophage Polarization As a Novel Weapon in Conditioning Tumor Microenvironment for Bladder Cancer: Can We Turn Demons into Gods? Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. Apr, 2019 | Pubmed ID: 30291519 Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring International Journal of Molecular Sciences. Aug, 2018 | Pubmed ID: 30149597 BMP4 Induces M2 Macrophage Polarization and Favors Tumor Progression in Bladder Cancer Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Dec, 2017 | Pubmed ID: 28928159 RNA Detection in Urine: From RNA Extraction to Good Normalizer Molecules The Journal of Molecular Diagnostics : JMD. Jan, 2016 | Pubmed ID: 26586227 EZH2 in Bladder Cancer, a Promising Therapeutic Target International Journal of Molecular Sciences. Nov, 2015 | Pubmed ID: 26580594 Un protocole préanalytique normalisé de biopsie liquide pour les applications d’ADN libre circulant en aval Julie Earl1, Silvia Calabuig-Fariñas1, María Eugenia Sarasquete1, Laura Muinelo Romay1, Sara Lopez-Tarruella1, Beatriz Bellosillo Paricio1, Marta Rodríguez1, Karmele Valencia Leoz1, Marta Dueñas Porto1, Noelia Tarazona1, Javier Hernandez Losa1, Rodrigo Almeida Toledo1 1The Liquid Biopsy and Biomarker Working Module, the Biomedical Research Network in Cancer (CIBERONC) JoVE 64123 Cancer Research
Un protocole préanalytique normalisé de biopsie liquide pour les applications d’ADN libre circulant en aval Julie Earl1, Silvia Calabuig-Fariñas1, María Eugenia Sarasquete1, Laura Muinelo Romay1, Sara Lopez-Tarruella1, Beatriz Bellosillo Paricio1, Marta Rodríguez1, Karmele Valencia Leoz1, Marta Dueñas Porto1, Noelia Tarazona1, Javier Hernandez Losa1, Rodrigo Almeida Toledo1 1The Liquid Biopsy and Biomarker Working Module, the Biomedical Research Network in Cancer (CIBERONC) JoVE 64123 Cancer Research
